Acutaas Chemicals Ltd (ACUA)

Currency in INR
3,777.30
-126.70(-3.25%)
Closed·
ACUTAAS is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
3,759.003,953.90
52 wk Range
1,570.004,045.30
Key Statistics
Bid/Ask
3,777.30 / 3,777.30
Prev. Close
3,777.3
Open
3,900
Day's Range
3,759-3,953.9
52 wk Range
1,570-4,045.3
Volume
373.99K
Average Volume (3m)
485.94K
1-Year Change
105.926%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ACUTAAS Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
3,649.67
Downside
-3.38%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low P/E ratio relative to near-term earnings growth

Acutaas Chemicals Ltd News & Analysis

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Strong Sell
Moving Averages
Neutral

Analyst Ratings

7 Buy
0 Hold
2 Sell
Ratings:
9 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 3,649.67
(-3.38% Downside)

Acutaas Chemicals Ltd Earnings Call Summary for Q2/2027

  • Q2 revenue surged 42.7% YoY to INR 4,369M, beating forecasts by 16.5%; EBITDA margin expanded 914 bps to 40.3%; shares jumped 13.35% to $3,796.
  • FY27 revenue growth guidance raised to ~30% from 25%; EBITDA margin guidance increased to 38%-40%; CDMO business to hit INR 1,000 crore one year early.
  • Company targets INR 2,000 crore CDMO revenue by FY30; plans INR 3,000M capex in FY27 for electronic chemicals and battery additives expansion.
  • Management aims to diversify beyond pharma into battery and semiconductor chemicals; first commercial battery revenue started with ramp-up over next 2-3 quarters.
  • Working capital rose to 115 days from 99; specialty chemicals remain muted; semiconductor projects still in qualification phase with revenue expected from FY28.
Last Updated: 27/10/2026, 10:42 pm
Read Full Transcript

Earnings

Latest Release
27/10/2026
EPS / Forecast
15.10 / 11.05
Revenue / Forecast
4.37B / 3.75B
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 53.65
Dividend Yield
0.06%
Industry Median 0.79%
Annualised payout
2.50
Paid annually
5-Years Growth
-
Growth Streak

ACUTAAS Income Statement

Compare ACUTAAS to Peers and Sector

Metrics to compare
ACUTAAS
Peers
Sector
Relationship
P/E Ratio
72.8x36.9x−0.3x
PEG Ratio
0.770.560.00
Price/Book
17.2x4.3x2.6x
Price / LTM Sales
20.1x5.0x2.8x
Upside (Analyst Target)
−3.4%9.3%67.2%
Fair Value Upside
Unlock−1.9%10.1%Unlock

Acutaas Chemicals Limited engages in the research and development, manufacture, and sale of pharmaceutical intermediates in India and internationally. The company offers pharma intermediates for use in regulated and generic active pharmaceutical ingredients, as well as new chemical entities. It also provides specialty chemicals, including photoresist chemicals for semiconductor applications; electrolyte additives for lithium battery cells; and parabens, methyl salicylate, and other commodity chemicals for cosmetics, agrochemicals, and fine chemicals. The company was formerly known as Ami Organics Limited and changed its name to Acutaas Chemicals Limited in May 2025. Acutaas Chemicals Limited was founded in 2004 and is based in Surat, India.

Industry
Chemicals
Employees
1007
Market
India

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
23.05M28.16%89.74B
Other Institutional Investors
4.09M4.99%15.90B
Public Companies & Retail Investors
54.73M66.85%213.05B
Total
81.87M100.00%318.69B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Norges Bank Investment Management3.54%2,901,68711,295,107
Government Pension Fund Global3.54%2,895,42111,270,716

People Also Watch

1,512.60
SYRM
+1.45%
4,062.30
NETE
-0.62%
728.40
TDPS
+2.37%
4,430.80
SASE
+4.87%
1,840.00
ATHR
+2.51%

FAQ

What Is the Acutaas Chemicals (ACUTAAS) Stock Price Today?

The Acutaas Chemicals stock price today is 3,777.30 INR.

What Stock Exchange Does Acutaas Chemicals Trade On?

Acutaas Chemicals is listed and trades on the India National Stock Exchange.

What Is the Stock Symbol for Acutaas Chemicals?

The stock symbol for Acutaas Chemicals is "ACUTAAS."

Does Acutaas Chemicals Pay Dividends? What’s The Current Dividend Yield?

The Acutaas Chemicals dividend yield is 0.1%%.

What Is the Acutaas Chemicals Market Cap?

As of today, Acutaas Chemicals market cap is 309.25B INR.

What Is Acutaas Chemicals's Earnings Per Share (TTM)?

The Acutaas Chemicals EPS (TTM) is 53.65.

From a Technical Analysis Perspective, Is ACUTAAS a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Acutaas Chemicals Stock Split?

Acutaas Chemicals has split 1 times.

How Many Employees Does Acutaas Chemicals Have?

Acutaas Chemicals has 1007 employees.

What is the current trading status of Acutaas Chemicals (ACUTAAS)?

As of 04/11/2026, Acutaas Chemicals (ACUTAAS) is trading at a price of 3,777.30 INR, with a previous close of 3,777.30 INR. The stock has fluctuated within a day range of 3,759.00 INR to 3,953.90 INR, while its 52-week range spans from 1,570.00 INR to 4,045.30 INR.

What Is Acutaas Chemicals (ACUTAAS) Price Target According to Analysts?

The average 12-month price target for Acutaas Chemicals is 3,649.67 INR, with a high estimate of 4693 INR and a low estimate of 1783 INR. 7 analysts recommend buying the stock, while 2 suggest selling, leading to an overall rating of Buy. The stock has an -3.38% Downside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.